Dana Jones's most recent trade in Tourmaline Bio Inc was a trade of 58,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 27, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tourmaline Bio Inc | Susan Dana Jones | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 58,000 | 58,000 | - | - | Employee Stock Option (Right to Buy) | |
Zapata Computing Holdings ... | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
Zapata Computing Holdings ... | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 25,000 | 25,000 | - | 0 | Common Stock | |
Agilysys, Inc | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 968 | 16,666 (0%) | 0% | 0 | Common Stock | |
Zapata Computing Holdings ... | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 68,558 | 68,558 | - | - | Stock Option (Right to Buy) | |
Zapata Computing Holdings ... | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 68,558 | 68,558 | - | - | Stock Option (Right to Buy) | |
Agilysys, Inc | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 69.65 per share. | 24 May 2023 | 1,435 | 15,698 (0%) | 0% | 69.7 | 99,948 | Common Stock |
Agilysys, Inc | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 43.06 per share. | 08 Jun 2022 | 2,322 | 14,263 (0%) | 0% | 43.1 | 99,985 | Common Stock |
Agilysys, Inc | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 1,435 | 11,941 (0%) | 0% | 0 | Common Stock | |
Agilysys, Inc | Dana Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 4,388 | 10,506 (0%) | 0% | 0 | Common Stock |